Goldman Sachs Group Inc Adaptive Biotechnologies Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,749,147 shares of ADPT stock, worth $7.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,749,147
Previous 1,048,012 66.9%
Holding current value
$7.73 Million
Previous $3.79 Million 136.09%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $2.36 Million - $3.59 Million
701,135 Added 66.9%
1,749,147 $8.96 Million
Q2 2024

Aug 13, 2024
BUY
$2.34 - $3.96 $985,820 - $1.67 Million
421,291 Added 67.22%
1,048,012 $3.79 Million
Q1 2024

May 15, 2024
SELL
$2.88 - $4.8 $510,736 - $851,227
-177,339 Reduced 22.06%
626,721 $2.01 Million
Q4 2023

Feb 13, 2024
SELL
$3.46 - $5.33 $3.09 Million - $4.76 Million
-893,114 Reduced 52.62%
804,060 $3.94 Million
Q3 2023

May 14, 2024
BUY
$5.07 - $8.44 $4.53 Million - $7.54 Million
893,114 Added 111.08%
1,697,174 $9.25 Million
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $2.29 Million - $3.82 Million
-452,056 Reduced 21.03%
1,697,174 $9.25 Million
Q2 2023

May 14, 2024
BUY
$6.19 - $8.78 $4.02 Million - $5.7 Million
649,493 Added 43.31%
2,149,230 $14.4 Million
Q2 2023

Aug 14, 2023
BUY
$6.19 - $8.78 $4.02 Million - $5.7 Million
649,493 Added 43.31%
2,149,230 $14.4 Million
Q1 2023

May 14, 2024
BUY
$7.8 - $10.11 $1.63 Million - $2.11 Million
209,162 Added 16.21%
1,499,737 $13.2 Million
Q1 2023

May 11, 2023
BUY
$7.8 - $10.11 $1.63 Million - $2.11 Million
209,162 Added 16.21%
1,499,737 $13.2 Million
Q4 2022

May 14, 2024
SELL
$6.26 - $9.34 $3.86 Million - $5.75 Million
-616,014 Reduced 32.31%
1,290,575 $9.86 Million
Q4 2022

Feb 13, 2023
SELL
$6.26 - $9.34 $3.86 Million - $5.75 Million
-616,014 Reduced 32.31%
1,290,575 $9.86 Million
Q3 2022

May 14, 2024
BUY
$6.5 - $12.67 $3.68 Million - $7.17 Million
566,107 Added 42.23%
1,906,589 $13.6 Million
Q3 2022

Nov 10, 2022
BUY
$6.5 - $12.67 $3.68 Million - $7.17 Million
566,107 Added 42.23%
1,906,589 $13.6 Million
Q2 2022

May 14, 2024
BUY
$6.4 - $14.73 $3.43 Million - $7.9 Million
536,422 Added 66.71%
1,340,482 $10.8 Million
Q2 2022

Aug 15, 2022
BUY
$6.4 - $14.73 $1.05 Million - $2.42 Million
164,380 Added 13.98%
1,340,482 $10.8 Million
Q1 2022

May 16, 2022
SELL
$10.12 - $28.9 $1.45 Million - $4.14 Million
-143,271 Reduced 10.86%
1,176,102 $16.3 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $1.21 Million - $1.77 Million
47,975 Added 3.77%
1,319,373 $37 Million
Q3 2021

Nov 10, 2021
BUY
$30.02 - $39.87 $38.2 Million - $50.7 Million
1,271,398 New
1,271,398 $43.2 Million

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $631M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email